FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123160735> ?p ?o ?g. }

• W2123160735 endingPage "4528" @default.
• W2123160735 startingPage "4520" @default.
• W2123160735 abstract "Purpose We previously reported that constitutive STAT3 activation is a prominent feature of the activated B-cell subtype of diffuse large B-cell lymphomas (ABC-DLBCL). In this study, we investigated whether STAT3 activation can risk stratify patients with DLBCL. Patients and Methods By an immunohistochemical method, we investigated phosphotyrosine STAT3 (PY-STAT3) expression from 185 patients with DLBCL treated with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone). Cell line-based siRNA experiments were also performed to generate an 11-gene, PY-STAT3 activation signature, which was used to study a previously published cohort of 222 patients with DLBCL. The STAT3 activation status determined by these two methods and by STAT3 mRNA levels were then correlated with survival. Results PY-STAT3 was detected in 37% of DLBCL and enriched in ABC-DLBCL cases (P = .03). PY-STAT3 positivity significantly correlated with poor overall survival (OS; P = .01) and event-free survival (EFS; P = .006). Similar observations were made for high levels of STAT3 mRNA. In multivariable analysis, PY-STAT3 status (P = .02), International Prognostic Index (P = .02), and BCL2 expression (P = .046) were independent prognosticators of OS in this cohort. Among the cell-of-origin subgroups, PY-STAT3 was associated with poor EFS among non–germinal center B-cell DLBCL cases only (P = .027). Similarly, the 11-gene STAT3 activation signature correlated with poor survival in the entire DLBCL cohort (OS, P < .001; EFS, P < .001) as well as the ABC-DLBCL subgroup (OS, P = .029; EFS, P = .025). Conclusion STAT3 activation correlated with poor survival in patients with DLBCL treated with R-CHOP, especially those with tumors of the ABC-DLBCL subtype." @default.
• W2123160735 created "2016-06-24" @default.
• W2123160735 creator A5001659843 @default.
• W2123160735 creator A5007992496 @default.
• W2123160735 creator A5014743270 @default.
• W2123160735 creator A5015247283 @default.
• W2123160735 creator A5019541879 @default.
• W2123160735 creator A5022164102 @default.
• W2123160735 creator A5025326711 @default.
• W2123160735 creator A5025942951 @default.
• W2123160735 creator A5028397596 @default.
• W2123160735 creator A5031758990 @default.
• W2123160735 creator A5040593611 @default.
• W2123160735 creator A5040831062 @default.
• W2123160735 creator A5041701143 @default.
• W2123160735 creator A5046438171 @default.
• W2123160735 creator A5046772434 @default.
• W2123160735 creator A5051379368 @default.
• W2123160735 creator A5059097260 @default.
• W2123160735 creator A5059337576 @default.
• W2123160735 creator A5059707915 @default.
• W2123160735 creator A5061471602 @default.
• W2123160735 creator A5066273890 @default.
• W2123160735 creator A5066731616 @default.
• W2123160735 creator A5075157221 @default.
• W2123160735 creator A5076637635 @default.
• W2123160735 creator A5080373697 @default.
• W2123160735 creator A5081888684 @default.
• W2123160735 creator A5084958568 @default.
• W2123160735 creator A5089779163 @default.
• W2123160735 date "2013-12-20" @default.
• W2123160735 modified "2023-10-13" @default.
• W2123160735 title "Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP" @default.
• W2123160735 cites W1966083469 @default.
• W2123160735 cites W1976564639 @default.
• W2123160735 cites W1977532256 @default.
• W2123160735 cites W1980494624 @default.
• W2123160735 cites W1985361684 @default.
• W2123160735 cites W1992320631 @default.
• W2123160735 cites W2007739717 @default.
• W2123160735 cites W2009002059 @default.
• W2123160735 cites W2017411379 @default.
• W2123160735 cites W2018116321 @default.
• W2123160735 cites W2026496740 @default.
• W2123160735 cites W2030105242 @default.
• W2123160735 cites W2037796411 @default.
• W2123160735 cites W2042996682 @default.
• W2123160735 cites W2044227662 @default.
• W2123160735 cites W2057862856 @default.
• W2123160735 cites W2058015212 @default.
• W2123160735 cites W2060267149 @default.
• W2123160735 cites W2067637255 @default.
• W2123160735 cites W2068713081 @default.
• W2123160735 cites W2069818613 @default.
• W2123160735 cites W2070217465 @default.
• W2123160735 cites W2082376914 @default.
• W2123160735 cites W2082787552 @default.
• W2123160735 cites W2089319072 @default.
• W2123160735 cites W2096984838 @default.
• W2123160735 cites W2099187439 @default.
• W2123160735 cites W2102602525 @default.
• W2123160735 cites W2110053604 @default.
• W2123160735 cites W2116382435 @default.
• W2123160735 cites W2126223232 @default.
• W2123160735 cites W2128822995 @default.
• W2123160735 cites W2129091720 @default.
• W2123160735 cites W2129272684 @default.
• W2123160735 cites W2136426653 @default.
• W2123160735 cites W2138498369 @default.
• W2123160735 cites W2139954541 @default.
• W2123160735 cites W2141048422 @default.
• W2123160735 cites W2145304413 @default.
• W2123160735 cites W2147246240 @default.
• W2123160735 cites W2157009395 @default.
• W2123160735 cites W2159175157 @default.
• W2123160735 cites W4210490242 @default.
• W2123160735 doi "https://doi.org/10.1200/jco.2012.45.6004" @default.
• W2123160735 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3871513" @default.
• W2123160735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24220563" @default.
• W2123160735 hasPublicationYear "2013" @default.
• W2123160735 type Work @default.
• W2123160735 sameAs 2123160735 @default.
• W2123160735 citedByCount "106" @default.
• W2123160735 countsByYear W21231607352013 @default.
• W2123160735 countsByYear W21231607352014 @default.
• W2123160735 countsByYear W21231607352015 @default.
• W2123160735 countsByYear W21231607352016 @default.
• W2123160735 countsByYear W21231607352017 @default.
• W2123160735 countsByYear W21231607352018 @default.
• W2123160735 countsByYear W21231607352019 @default.
• W2123160735 countsByYear W21231607352020 @default.
• W2123160735 countsByYear W21231607352021 @default.
• W2123160735 countsByYear W21231607352022 @default.
• W2123160735 countsByYear W21231607352023 @default.
• W2123160735 crossrefType "journal-article" @default.
• W2123160735 hasAuthorship W2123160735A5001659843 @default.
• W2123160735 hasAuthorship W2123160735A5007992496 @default.
• W2123160735 hasAuthorship W2123160735A5014743270 @default.

• next